Coverage
-
January 23, 2020
Alkem Laboratories shouldn't be allowed to sell a generic version of Assertio Therapeutics' opioid painkiller Nucynta ER three years earlier than an injunction allows after changing its drug's label to dodge a patent, Assertio has told a New Jersey federal court.
4 other articles on this case.
View all »